Landos Biopharma Inc.   Report issue

For profit Phase 1 Phase 2
Founded: Blacksburg VA United States (2017)

Organization Overview

First Clinical Trial
2018
NCT03860571
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Landos Biopharma Inc.